Cognition and Quality of Life After Chemotherapy Plus Radiotherapy (RT) vs. RT for Pure and Mixed Anaplastic Oligodendrogliomas: Radiation Therapy Oncology Group Trial 9402

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 3, 2010, Pages 662-669

  Wang, Meihua ^a   Cairncross, Gregory ^b   Shaw, Edward ^c   Jenkins, Robert ^d   Scheithauer, Bernd ^d   Brachman, David ^e   Buckner, Jan ^d   Fink, Karen ^f   Souhami, Luis ^g   Laperriere, Normand ^h   Mehta, Minesh ⁱ   Curran, Walter ^j  

^a AMERICAN COLLEGE OF RADIOLOGY   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

^e Foundation for Cancer Research and Education   (United States)

^f BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ UNIVERSITY OF WISCONSIN MADISON   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Cognitive function; PCV; Quality of life; Radiotherapy; Randomized trial

Indexed keywords

COGNITIVE FUNCTIONS; DROP-OUT; OLIGODENDROGLIOMA; PARAMETER MODEL; PCV; QUALITY OF LIFE; RADIATION THERAPY; RADIATION THERAPY ONCOLOGY GROUPS; RANDOMIZED TRIAL;

BRAIN; CHEMOTHERAPY; ONCOLOGY;

RADIOTHERAPY;

LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADULT; AGE; ARTICLE; BRAIN SURGERY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SURVIVOR; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; MULTIPLE CYCLE TREATMENT; OLIGODENDROGLIOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; COGNITION; COMBINED MODALITY THERAPY; HUMANS; KARNOFSKY PERFORMANCE STATUS; LOMUSTINE; LONGITUDINAL STUDIES; MENTAL STATUS SCHEDULE; MIDDLE AGED; OLIGODENDROGLIOMA; PROCARBAZINE; QUALITY OF LIFE; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 77952557556     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.06.004     Document Type: Article

References (32)

1. Cairncross J.G., Macdonald D.R., and Ramsay D.A. Aggressive oligodendroglioma: A chemosensitive tumor. Neurosurgery 31 (1992) 78-82
2. Cairncross G., Berkey B., Shaw E., et al. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiotherapy Oncology Group Trial 9402. J Clin Oncol 24 (2006) 2707-2714
3. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-18
4. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
5. Aaronson N.K., Bakker W., Stewart A.L., et al. Multidimensional approach to the measurement of quality of life in lung cancer clinical trials. In: Aaronson N.K., and Beckmann J. (Eds). The quality of life of cancer patients (1987), Raven Press, New York 63-82
6. Mackworth N., Fobair P., and Prados M.D. Quality of life self-reports from 200 brain tumor patients: comparison with Karnofsky performance scores. J neuro-Oncol 14 (1992) 243-253
7. Fairclough D. Design and analysis of quality of life studies in clinical trials (2003), Chapman & Hall/CRC, Boca Raton, FL
8. Cohen J. Statistical power analysis for the behavioral sciences (1988), Lawrence Erlbaum Associates, Hillsdale, NJ
9. Sloan J., Cella D., and Hays R. Clinical significance of patient-reported questionnaire data: Another step toward consensus. J Clin Epidemiol 58 (2005) 1217-1219
10. Vonesh E.F., Greene T., and Schluchter M.D. Shared parameter models for the joint analysis of longitudinal data and event times. Stat Med 25 (2006) 143-163
11. Zeng D., and Cai J. Simultaneous modeling of quality of life and survival time. Lifetime Data Anal 11 (2005) 151-174
12. Henderson R., Diggle P., and Dobson A. Joint modelling of longitudinal measurements and event time data. Biostatistics 1 (2000) 465-480
13. Guo X., and Carlin B. Separate and joint modeling of longitudinal and event time data using standard computer packages. Am Stat 58 (2004) 16-24
14. Cairncross G., Wang M., Shaw E., et al. A randomized trial of chemotherapy plus radiotherapy (RT) versus RT alone for anaplastic oligodendroglioma (RTOG 9402): The perspective of longer follow-up [abstract]. Int J Radiat Oncol Biol Phys 72 Suppl 1 (2008) S206
15. Klein J., and Moeschberger M. Survival analysis: techniques for censored and truncated data (2003), Springer, New York
16. Imperato J.P., Paleologos N.A., and Vick N.A. Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 28 (1990) 818-822
17. Lezak M.D., Howieson D.B., Loring D.W., et al. Neuropsychological assessment. 4th ed. (2004), Oxford University Press, Oxford
18. Meyers C., Hess K., Yung W., et al. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 18 (2000) 646-650
19. Tombaugh T.N., and McIntyre N.J. The Mini-Mental State Examination: A comprehensive review. J Am Geriatr Soc 40 (1992) 922-935
20. Salmon D., Thal L., Butters N., et al. Longitudinal evaluation of dementia of the Alzheimer type: A comparison of 3 standardized mental status examinations. Neurology 40 (1990) 1225
21. Galasko D., Klauber M.R., Hofstetter C.R., et al. The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease. Arch Neurol 47 (1990) 49-52
22. Wade D.T. Measurement in neurological rehabilitation (1992), Oxford University Press, Oxford
23. Mehta M.P., Shapiro W.R., Glantz M.J., et al. Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: Centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. J Clin Oncol 20 (2002) 3445-3453
24. Mehta M.P., Rodrigus P., Terhaard C.H.J., et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 21 (2003) 2529-2536
25. Meyers C.A., Smith J.A., Bezjak A., et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: Results of a randomized phase III trial. J Clin Oncol 22 (2004) 157-165
26. Bosma I., Vos M.J., Heimans J.J., et al. The course of neurocognitive functioning in high-grade glioma patients. Neuro Oncol 9 (2007) 53-62
27. Li J., Bentzen S.M., Li J., et al. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int J Radiat Oncol Biol Phys 71 (2008) 64-70
28. Taylor B.V., Buckner J.C., Cascino T.L., et al. Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol 16 (1998) 2195-2201
29. Corn B.W., Moughan J., Knisely J.P.S., et al. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) Trial 0118. Int J Radiat Oncol Biol Phys 71 (2008) 71-78
30. Murray K.J., Scott C., Zachariah B., et al. Importance of the mini-mental status examination in the treatment of patients with brain metastases: A report from the Radiation Therapy Oncology Group protocol 91-04. Int J Radiat Oncol Biol Phys 48 (2000) 59-64
31. Brown P.D., Jensen A.W., Felten S.J., et al. Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J Clin Oncol 24 (2006) 5427-5433
32. Brown P.D., Buckner J.C., O'Fallon J.R., et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein mini-mental state examination. J Clin Oncol 21 (2003) 2519-2524